Literature DB >> 26830893

Prevention of Depression in At-Risk Adolescents: Moderators of Long-term Response.

J Garber1, V R Weersing2,3, S D Hollon4, G Porta5, G N Clarke6, J F Dickerson6, W R Beardslee7, F L Lynch6, T G Gladstone8, W Shamseddeen9, D A Brent5.   

Abstract

In a randomized controlled trial, we found that a cognitive behavioral program (CBP) was significantly more effective than usual care (UC) in preventing the onset of depressive episodes, although not everyone benefitted from the CBP intervention. The present paper explored this heterogeneity of response. Participants were 316 adolescents (M age = 14.8, SD = 1.4) at risk for depression due to having had a prior depressive episode or having current subsyndromal depressive symptoms and having a parent with a history of depression. Using a recursive partitioning approach to baseline characteristics, we (Weersing et al. 2016) previously had identified distinct risk clusters within conditions that predicted depressive episodes through the end of the continuation phase (month 9). The present study used the same risk clusters that had been derived in the CBP group through month 9 to reclassify the UC group and then to examine group differences in depression through month 33. We found that in this overall very high-risk sample, the CBP program was superior to UC among youth in the low-risk cluster (n = 33), characterized by higher functioning, lower anxiety, and parents not depressed at baseline, but not in the middle (n = 95) and high-risk (n = 25) clusters. Across conditions, significantly more depression-free days were found for youth in the low-risk cluster (M = 951.9, SD = 138.8) as compared to youth in the high-risk cluster (M = 800.5, SD = 226.7). Identification of moderators, based on purely prognostic indices, allows for more efficient use of resources and suggests possible prevention targets so as to increase the power of the intervention.

Entities:  

Keywords:  Adolescents; Depression; Moderators; Prevention

Mesh:

Year:  2018        PMID: 26830893      PMCID: PMC4969230          DOI: 10.1007/s11121-015-0626-z

Source DB:  PubMed          Journal:  Prev Sci        ISSN: 1389-4986


  29 in total

Review 1.  Mediators and moderators of treatment effects in randomized clinical trials.

Authors:  Helena Chmura Kraemer; G Terence Wilson; Christopher G Fairburn; W Stewart Agras
Journal:  Arch Gen Psychiatry       Date:  2002-10

2.  Prevention of Depression in At-Risk Adolescents: Predictors and Moderators of Acute Effects.

Authors:  V Robin Weersing; Wael Shamseddeen; Judy Garber; Steven D Hollon; Gregory N Clarke; William R Beardslee; Tracy R Gladstone; Frances L Lynch; Giovanna Porta; Satish Iyengar; David A Brent
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2016-01-18       Impact factor: 8.829

3.  Incremental cost-effectiveness of combined therapy vs medication only for youth with selective serotonin reuptake inhibitor-resistant depression: treatment of SSRI-resistant depression in adolescents trial findings.

Authors:  Frances L Lynch; John F Dickerson; Greg Clarke; Benedetto Vitiello; Giovanna Porta; Karen D Wagner; Graham Emslie; Joan Rosenbaum Asarnow; Martin B Keller; Boris Birmaher; Neal D Ryan; Betsy Kennard; Taryn Mayes; Lynn DeBar; James T McCracken; Michael Strober; Robert L Suddath; Anthony Spirito; Matthew Onorato; Jamie Zelazny; Satish Iyengar; David Brent
Journal:  Arch Gen Psychiatry       Date:  2011-03

4.  Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression.

Authors:  Jay C Fournier; Robert J DeRubeis; Richard C Shelton; Steven D Hollon; Jay D Amsterdam; Robert Gallop
Journal:  J Consult Clin Psychol       Date:  2009-08

5.  A meta-analytic review of depression prevention programs for children and adolescents: factors that predict magnitude of intervention effects.

Authors:  Eric Stice; Heather Shaw; Cara Bohon; C Nathan Marti; Paul Rohde
Journal:  J Consult Clin Psychol       Date:  2009-06

6.  The use of the Center for Epidemiologic Studies Depression Scale in adolescents and young adults.

Authors:  L S Radloff
Journal:  J Youth Adolesc       Date:  1991-04

7.  Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial.

Authors:  David Brent; Graham Emslie; Greg Clarke; Karen Dineen Wagner; Joan Rosenbaum Asarnow; Marty Keller; Benedetto Vitiello; Louise Ritz; Satish Iyengar; Kaleab Abebe; Boris Birmaher; Neal Ryan; Betsy Kennard; Carroll Hughes; Lynn DeBar; James McCracken; Michael Strober; Robert Suddath; Anthony Spirito; Henrietta Leonard; Nadine Melhem; Giovanna Porta; Matthew Onorato; Jamie Zelazny
Journal:  JAMA       Date:  2008-02-27       Impact factor: 56.272

8.  The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies.

Authors:  M B Keller; P W Lavori; B Friedman; E Nielsen; J Endicott; P McDonald-Scott; N C Andreasen
Journal:  Arch Gen Psychiatry       Date:  1987-06

9.  Mental health and functional outcomes of maternal and adolescent reports of adolescent depressive symptoms.

Authors:  Frances Rice; Kate J Lifford; Hollie V Thomas; Anita Thapar
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2007-09       Impact factor: 8.829

Review 10.  Survival analysis part IV: further concepts and methods in survival analysis.

Authors:  T G Clark; M J Bradburn; S B Love; D G Altman
Journal:  Br J Cancer       Date:  2003-09-01       Impact factor: 7.640

View more
  2 in total

Review 1.  Evidence Base Update of Psychosocial Treatments for Child and Adolescent Depression.

Authors:  V Robin Weersing; Megan Jeffreys; Minh-Chau T Do; Karen T G Schwartz; Carl Bolano
Journal:  J Clin Child Adolesc Psychol       Date:  2016-11-21

2.  Prevention programmes for children of parents with a mood/anxiety disorder: Systematic review of existing programmes and meta-analysis of their efficacy.

Authors:  Petra J Havinga; Dominique F Maciejewski; Catharina A Hartman; Manon H J Hillegers; Robert A Schoevers; Brenda W J H Penninx
Journal:  Br J Clin Psychol       Date:  2021-01-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.